MLICM
JAZZ icon

Metropolitan Life Insurance Company (MetLife)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,968
Closed -$1.4M – 2463
2021
Q4 		$1.4M Sell
10,968
-159
-1% -$20.9K 0.02% 731
2021
Q3 		$1.45M Sell
11,127
-212
-2% -$32K 0.02% 705
2021
Q2 		$2.01M Buy
11,339
+714
+7% +$124K 0.03% 522
2021
Q1 		$1.75M Buy
10,625
+666
+7% +$110K 0.03% 585
2020
Q4 		$1.64M Sell
9,959
-225
-2% -$33.5K 0.02% 574
2020
Q3 		$1.45M Buy
10,184
+9,083
+825% +$1.13M 0.02% 549
2020
Q2 		$121K Sell
1,101
-2,496
-69% -$276K ﹤0.01% 2134
2020
Q1 		$359K Sell
3,597
-108
-3% -$14K 0.01% 1248
2019
Q4 		$553K Sell
3,705
-67
-2% -$9.12K 0.01% 1263
2019
Q3 		$483K Sell
3,772
-324
-8% -$43.4K 0.01% 1317
2019
Q2 		$584K Sell
4,096
-93
-2% -$12.5K 0.01% 1211
2019
Q1 		$599K Sell
4,189
-87
-2% -$11.3K 0.01% 1175
2018
Q4 		$530K Sell
4,276
-12
-0.3% -$1.78K 0.01% 1158
2018
Q3 		$721K Sell
4,288
-95
-2% -$16.3K 0.01% 1112
2018
Q2 		$755K Buy
+4,383
New +$716K 0.01% 1065
2014
Q3 		– Sell
-4,105
Closed -$599K – 2698
2014
Q2 		$599K Buy
4,105
+538
+15% +$74.6K ﹤0.01% 1704
2014
Q1 		$451K Hold
3,567
– – ﹤0.01% 1880
2013
Q4 		$451K Hold
3,567
– – ﹤0.01% 1879
2013
Q3 		$328K Sell
3,567
-48
-1% -$3.87K ﹤0.01% 2041
2013
Q2 		$248K Buy
+3,615
New +$221K ﹤0.01% 2200

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s JAZZ Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2022, closing a stake of 10,968 shares — an estimated $1.4M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in JAZZ in Q2 2013 and held it in 20 quarters. The position peaked at $2.01M in Q2 2021. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Jazz Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 10,968 Jazz Pharmaceuticals shares in Q1 2022, an estimated $1.4M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Jazz Pharmaceuticals position peaked at $2.01M in Q2 2021.
  • 462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.